6F., No. 244, Sec. 3, Chengde Rd., Datong Dist., Taipei City 103, Taiwan tgcc@greencross.com.tw
Home/Partnership/International Cooperation
International Cooperation

Diverse partnership models, lasting cross-border connections

Building on import distribution, Green Cross extends into technology collaboration, joint marketing and cross-border academic exchange,
offering a complete and flexible framework for international manufacturers entering Taiwan and for local products reaching the Asia-Pacific.

Overview

The many forms of cross-border cooperation

We are more than a distribution partner for international manufacturers entering Taiwan. Through the export of our own Urokinase 60,000 IU,
and through academic collaboration with medical teams across the Asia-Pacific, we build two-way, mutually beneficial cross-border connections.

We believe that stable, long-term collaboration is worth far more than short-term transactions; every partnership we build is a shared investment in the future of healthcare.

Distribution — bringing quality international pharmaceutical products to Taiwan
Taiwan Green Cross Distribution

Distribution Partnership

With more than fifty years of experience in Taiwan's healthcare market, we continuously seek high-quality international pharmaceutical products with strong clinical value and bring them to Taiwan, addressing unmet treatment needs and clinical challenges.

Our deep familiarity with Taiwan's healthcare system, market landscape and regulatory processes enables us to help international partners enter the Taiwan market effectively. We provide comprehensive, professional support from market assessment and regulatory submission to product launch and commercial promotion, building a stable foundation for long-term market development.

Taiwan Green Cross Licensing

Licensing Partnership

We offer international licensing opportunities for our Taiwan-manufactured thrombolytic agent. Originating from Japanese technology, the product has been used stably in Taiwan for nearly 40 years and has long been applied in hospital clinical practice, supported by a solid market foundation and extensive clinical experience.

We look forward to working with partners who share a long-term vision to develop the cardiovascular and thrombolytic treatment market together, and to building a stable, sustainable relationship. Drawing on our deep experience in clinical engagement, market promotion and product management, we serve as a dependable backbone for our partners, providing comprehensive support to drive market growth and long-term value together.

Licensing — international licensing of a Taiwan-manufactured thrombolytic agent
Registration — regulatory assessment and product registration for pharmaceuticals and medical devices
Taiwan Green Cross Registration

Regulatory Registration

We have extensive experience in regulatory assessment and product registration for pharmaceuticals, medical devices and cosmetics. With a thorough understanding of Taiwan's regulatory requirements and review procedures, we help partners plan registration strategies effectively, accelerate market entry and reduce product launch risk.

Taiwan Green Cross Commercialization

Market Development & Commercialization

With over fifty years of experience in the healthcare market, we understand Taiwan's healthcare channels at every level as well as clinical market needs. Our full range of product promotion and market development capabilities helps partners build a long-term, stable foundation for growth in the Taiwan market.

Commercialization — comprehensive channel coverage and promotional capability
Explore More

Discover our network

Global Markets

Explore our partnership network across Asia, Europe and the Americas on an interactive map.

View map

Partnership Inquiries

International manufacturers and partners interested in cross-border cooperation are welcome to reach us through our contact form.

Get in touch